Development of deep vein thrombosis during treatment with plasmapheresis.

4. Bordin G, Boldorini R, Meroni PL. The two hit hypothesis in the antiphospholipid syndrome: Acute ischaemic heart involvement after valvular replacement despite anticoagulation in a patient with secondary APS. Lupus. 2003;12:851–3. 5. Deák M, Bocskai M, Burcsár S, Dányi O, Fekete Z, Kovács L. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome. Lupus. 2014;23:913–8. 6. Gouya H, Cabanes L, Mouthon L, Pavie A, Legmann P, Vignaux O. Severe mitral stenosis as the first manifestation of systemic lupus erythematosus in a 20-year-old woman: The value of magnetic resonance imaging in the diagnosis of Libman-Sacks endocarditis. Int J Cardiovasc Imaging. 2014;30:959–60. 7. Vinales KL, Gopalan RS, Lanza LA, Lester SJ, Chaliki HP. Unusual case of nonbacterial thrombotic endocarditis attributable to primary antiphospholipid syndrome. Circulation. 2010;122:e459–60. 8. Nishioka N, Morimoto N, Yoshida M, Mukohara N. Left ventricular vegetations: A rare manifestation of Libman-Sacks endocarditis. J Thorac Cardiovasc Surg. 2013;145:e26–8. Nerea Gómez-Larrambea, Lourdes González-Tabarésa, Beatriz Millána, Carmen Cobeloa, Victor Armestob, Montserrat Pousa c, Secundino Cigarrán c y Jesus Calviñoa,∗